Retrospective diagnosis of immunoregulatory disorders in children requiring dispensary monitoring
- 作者: Penkina N.I.1, Ermolaeva N.N.2, Kudlay D.A.3,4, Prodeus A.P.5
-
隶属关系:
- Izhevsk State Medical Academy
- Republican Children's Clinical Hospital
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- NRC Institute of Immunology FMBA of Russia
- Research Clinical Institute of Childhood
- 期: 卷 34, 编号 5 (2023)
- 页面: 88-93
- 栏目: For Diagnosis
- URL: https://journals.eco-vector.com/0236-3054/article/view/472130
- DOI: https://doi.org/10.29296/25877305-2023-05-16
- ID: 472130
如何引用文章
详细
Objective. To find the relationship between the quantitative indicators of DNA TREC and KREC with three groups of pathological conditions: sudden death syndrome, frequent diseases of the bronchopulmonary system and allergic diseases.
Materials and methods. The study was conducted retrospectively. The survey group included infants and young children with various diseases, in which, based on the anamnesis, the presence of a pathology of the immune system was assumed. A total of 43 children were examined, of which group I - 5 children with sudden death syndrome, group II - 25 patients with frequent diseases of the bronchopulmonary system who received long-term antibiotic therapy, group III - 13 children with allergic diseases. Quantitative determination of TREC and KREC was carried out from samples of "dry spots" of blood obtained during neonatal screening.
Results. Low TREC values were recorded more frequently than low KREC values, found in 79.1% and 48.8%, respectively. In the group of patients with sudden death syndrome (I group), who died in the first - fourth months of life, there were high rates of intrauterine growth retardation, dysembryogenesis stigma, congenital malformations, intrauterine infections. This group of children is characterized by thymomegaly and hypoplasia of the adrenal glands, TREC and KREC values are reduced in all children. The group of children with a high frequency of bronchopulmonary diseases (Group II) is characterized by a persistent course of herpes virus infection, prolonged subfebrile condition, neutropenia, transient hypoimmunoglobulinemia A, and thymomegaly. Low TREC values were found in 88% of children of group II, KREC - in 32%. In the III group of patients with allergic diseases (bronchial asthma, atopic dermatitis, allergic rhinitis, food allergy), TREC values are reduced in 53.8% of children, KREC – in 61.5% of children. Children of this group often suffered ARI, laryngotracheitis, obstructive bronchitis. During the first months of life, 75% of children manifested atopic dermatitis. In 62.5% of children with allergic diseases, a low level of serum immunoglobulin A was detected.
Conclusions. Low values of TREC and KREC in a significant part of the examined patients make it possible to suspect the pathology of the immune system. The presence of diseases belonging to the group of warnings for the presence of primary immunodeficiency may also indicate the pathology of the immune system, primary or transient, due to infections, prematurity, intrauterine growth retardation, toxic effects. Comparison of the results of the survey in the neonatal period and diseases formed in infancy and early childhood was carried out retrospectively. The introduction in the Russian Federation of neonatal screening of primary immunodeficiencies based on the quantitative determination of TREC and KREC makes it possible to timely diagnose immunity errors and prescribe modern methods of treatment. However, the cut-off of the TREC and KREC values needs to be revised in the future.
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
N. Penkina
Izhevsk State Medical Academy
Email: ermolaeva-rdkb@mail.ru
ORCID iD: 0000-0003-4427-3900
Doctor of Medical Sciences
俄罗斯联邦, IzhevskN. Ermolaeva
Republican Children's Clinical Hospital
编辑信件的主要联系方式.
Email: ermolaeva-rdkb@mail.ru
ORCID iD: 0000-0001-9463-7384
俄罗斯联邦, Izhevsk
D. Kudlay
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; NRC Institute of Immunology FMBA of Russia
Email: ermolaeva-rdkb@mail.ru
ORCID iD: 0000-0003-1878-4467
Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences
俄罗斯联邦, Moscow; MoscowA. Prodeus
Research Clinical Institute of Childhood
Email: ermolaeva-rdkb@mail.ru
ORCID iD: 0000-0001-5435-1859
Doctor of Medical Sciences, Professor
俄罗斯联邦, Moscow参考
- Щербина А.Ю. Маски первичных иммунодефицитных состояний: проблемы диагностики и терапии. Российский журнал детской гематологии и онкологии. 2016; 3 (1): 52–8 [Shcherbina A.Yu. Masks of primary immunodeficiency disorders: diagnostic and therapeutic problems. Russian Journal of Pediatric Hematology and Oncology. 2016; 3 (1): 52–8 (in Russ.)]. doi: 10.17650/2311-1267-2016-3-1-52-58
- Tangye S.G., Al-Herz W., Bousfiha A. et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022; 42 (7): 1473–507. doi: 10.1007/s10875-022-01289-3
- Корсунский И.А., Гордукова М.А., Козлов И.Г. и др. Клинические и эпидемиологические аспекты первичных иммунодефицитных состояний и их раннего обнаружения. Медицинская иммунология. 2017; 19 (5): 505–12 [Korsunskiy I.A., Gordukova M.A., Munblit D.B., et al. Clinical and epidemiological aspects of primary immunodeficiency diseases (PID) and early diagnosis options. Medical Immunology (Russia). 2017; 19 (5): 505–12 (in Russ.)]. doi: 10.15789/1563-0625-2017-5-505-512
- Notarangelo L.D. Primary immunodeficiencies. J Allergy Clin Immunol. 2010; 125 (2 Suppl 2): S182–S194. doi: 10.1016/j.jaci.2009.07.053
- Хаитов Р.М., Пинегин В.Б. Иммунодефициты: диагностика и иммунотерапия. Лечащий врач. 1999; 2 (3): 63–9 [Khaitov R.M., Pinegin V.B. Immunodefitsity: diagnostika i immunoterapiya. Lechashchii vrach. 1999; 2 (3): 63–9 (in Russ.)].
- Кондратенко И.В., Болотов А.А. Первичные иммунодефициты. М.: ИД Медпрактика-М, 2005; 231 [Kondratenko I.V., Bolotov A.A. Pervichnye immunodefitsity. M.: ID Medpraktika-M, 2005; 231 (in Russ.)].
- Козлов В.А., Тихонова Е.П., Савченко А.А. и др. Клиническая иммунология. Практическое пособие для инфекционистов. Красноярск: Поликор, 2021; 563 c. [Kozlov V.A., Tikhonova E.P., Savchenko A.A. et al. Klinicheskaya immunologiya. Prakticheskoe posobie dlya infektsionistov. Krasnoyarsk: Polikor, 2021; 563 р. (in Russ.)]. doi: 10.17513/np.518
- Корсунский И.А., Гордукова М.А., Смирнова А.С. и др. Целесообразность неонатального скрининга первичных иммунодефицитных состояний. РМЖ. 2018: 9: 29–32 [Korsunskiy I.A., Gordukova M.A., Smirnova A.S. et al. Feasibility of neonatal screening in primary immunodeficiency diseases. RMJ. 2018; 9: 29–32 (in Russ.)].
- Гордукова М.А., Оскорбин И.П., Мишукова О.В. и др. Разработка набора реагентов для количественного определения молекул ДНК TREC и KREC в цельной крови и сухих пятнах крови методом мультиплексной ПЦР в режиме реального времени. Медицинская иммунология. 2015; 17 (5): 467–78 [Gordukova M.A., Oskorbin I.P., Mishukova O.V. et al. Development of real-time multiplex PCR for the quantitative determination of TREC's and KREC's in whole blood and in dried blood spots. Medical Immunology (Russia). 2015; 17 (5): 467–78 (in Russ.)]. doi: 10.15789/1563-0625-2015-5-467-478
- King J.R., Hammarström L. Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. J Clin Immunol. 2018; 38 (1): 56–66. doi: 10.1007/s10875-017-0455-x
- Донецкова А.Д. Новый подход к исследованию Т-лимфопоэза с помощью определения Т-рецепторных эксцизионных колец в эксперименте и клинике. Автореф. дисс. … д-ра мед. наук. М., 2013; 26 [Donetskova A.D. Novyi podkhod k issledovaniyu T-limfopoeza s pomoshch'yu opredeleniya T-retseptornykh ekstsizionnykh kolets v eksperimente i klinike. Avtoref. diss. … d-ra med. nauk. M., 2013; 26 (in Russ.)].
- Serana F., Sottini F., Chiarini M. et al. Use of V(D) J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acguired immunodeficiencies. J Transl Med. 2013; 11: 119. doi: 10.1186/1479-5876-11-119
- Филипенко М.Л., Румянцев А.Г., Продеус А.П. и др. Скрининг новорожденных на первичные иммунодефициты и группу риска иммунорегуляторных расстройств, требующих диспансерного наблюдения. Педиатрия им. Г.Н. Сперанского. 2019; 98 (3): 49–54 [Filipenko М.L., Rumyantsev A.G, Prodeus A.P. et al. Screening of newborns for primary immunodeficiencies and risk groups for immunoregulatory disorders requiring follow up. Pediatria n.a. G.N. Speransky. 2019; 98 (3): 49–54 (in Russ.)]. doi: 10.24110/0031-403X-2019-98-3-49-54
- Корсунский И.А., Кудлай Д.А., Продеус А.П. и др. Неонатальный скрининг на первичные иммунодефицитные состояния и Т-/В-клеточные лимфопении как основа формирования групп риска детей с врожденными патологиями. Педиатрия им. Г.Н. Сперанского. 2020; 99 (2): 8–15 [Korsunsky I.A., Kudlay D.A., Prodeus A.P. et al. Neonatal screening for primary immunodeficiency and Т-/B-cell lymphopenia as the basis for the formation of risk groups for children with congenital pathologies. Pediatria n.a. G.N. Speransky. 2020; 99 (2): 8–15 (in Russ.)]. doi: 10.24110/0031-403X-2020-99-2-8-15
- Verbski J., Thakar M., Rartes J. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2012; 129 (3): 622–7. doi: 10.1016/j.jaci.2011.12.004
- van der Spek J., Groenwold R.H.H., van der Burg M. et al. TREC basednewborn scrining for severe combined immune deficiency disease, a sysnematic review. J Clin Immunol. 2015; 35: 416–30. doi: 10.1007/s10875-015-0152-6
- Pai S.-Y., Logan B.R., Griffith L.M. Transplantacion Outcomes for Severe Combined immunodeficiency, 2000-2009. N Engl J Med. 2014; 371 (5): 434–46. doi: 10.1056/NEJMoa1401177
补充文件
![](/img/style/loading.gif)